Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $5.37 Million - $6.8 Million
-50,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $5.32 Million - $6.04 Million
50,000 New
50,000 $5.39 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $6.14 Million - $6.76 Million
-60,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $1.61 Million - $2.17 Million
-20,000 Reduced 25.0%
60,000 $6.43 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $6.87 Million - $8.07 Million
80,000 New
80,000 $7.01 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $15.1 Million - $19 Million
-210,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $6.93 Million - $8.33 Million
110,000 Added 110.0%
210,000 $15.9 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $6.57 Million - $8.4 Million
100,000 New
100,000 $7.27 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Btg Pactual Global Asset Management LTD Portfolio

Follow Btg Pactual Global Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.